The Lancet Diabetes and Endocrinology: Job strain linked to increased risk of premature death for men with cardiometabolic disease

June 05, 2018

Having a demanding job and little control over it is associated with an increased risk of premature death in men with coronary heart disease, stroke, or diabetes, according to an observational study tracking more than 100000 men and women with and without cardiometabolic disease from Finland, France, Sweden, and the UK for almost 14 years, published in The Lancet Diabetes & Endocrinology journal.

However, there was no association between any type of work stress and premature death for women with or without cardiometabolic disease. Men without cardiometabolic disease had a slightly heightened risk of death associated with work that demands a lot of effort for little reward. Some existing treatment guidelines already recommend stress management for people with cardiometabolic disease, but this study is the first large-scale study to investigate the link.

"Work is a common source of stress in adulthood, triggering natural stress responses that were programmed in our bodies generations ago. These can result in physical reactions to situations like work stress, and our findings give evidence for there being a link between job strain and risk of premature death in men with cardiometabolic diseases, such as coronary heart disease, stroke, and diabetes," says Professor Mika Kivimäki, UCL, UK. "These findings suggest that controlling blood pressure and cholesterol levels alone are unlikely to eliminate the excess risk associated with job strain in men with cardiometabolic disease. Other interventions might be needed at least for some patients - possibly including stress management as part of cardiovascular disease rehabilitation, job redesign, or reducing working hours. However, more research will be needed to identify which specific interventions might improve health outcomes in men with coronary heart disease, stroke, or diabetes." [1]

The study, which began in 1985, is the largest of its kind and includes seven cohort studies from Finland, France, Sweden, and the UK. It included 102633 men and women - including 3441 with cardiometabolic disease (1975 men and 1466 women) - who were given a questionnaire on their lifestyle and health at the start of the study. Participants' medical records were tracked for an average of 13.9 years, and during this time 3841 participants died.

The study included two types of work stress; job strain (having high work demands and low control over them) and effort-reward imbalance (putting in lots of effort, but getting little reward in return).

After controlling for socioeconomic status and several conventional and lifestyle risk factors (including high blood pressure, high cholesterol, smoking, obesity, physical inactivity, and high alcohol consumption), the authors found that, among men with cardiometabolic disease, those experiencing job strain had a 68% greater risk of premature death than men who had no job strain [2].

In addition, this increased risk was even present in men with cardiometabolic disease who had achieved their treatment targets, including those with a healthy lifestyle (including not being obese, being physically active, not smoking, and not drinking heavily), blood pressure, and cholesterol levels.

There was no association between risk of premature death and effort-reward imbalance in men with cardiometabolic disease, but men without cardiometabolic disease had a slightly heightened risk associated with this type of work stress.

Neither type of work stress was associated with increased mortality risk for women with or without cardiometabolic disease.

The authors say that job stress may affect the body in a number of ways to cause this association, including hijacking natural responses to stress, through heightened levels of the stress hormone cortisol, which increases glucose production and limits the effect of insulin, potentially leading to worse prognosis in diabetes. In addition, increased inflammation and increased activation of the 'fight-or-flight' response can elevate blood pressure and affect blood clotting, potentially increasing the risk of cardiac events in individuals who already have high levels of hardening of the arteries.

The authors note some limitations, including that the study only measured cardiometabolic disease and work stress at the start of the study, meaning it does not account for severity of disease or how it changes over time. The study did not control for blood pressure or cholesterol levels in all cohorts due to missing data, and this could lead to a small overestimation of the effect of job strain.

Equally, the authors note that people with more severe cardiometabolic disease tend to shorten their working hours, and this reduced effort may explain why there is no association between effort-reward imbalance and risk of premature mortality in men with cardiometabolic disease.

Writing in a linked Comment, Yulong Lian, Nantong University, China, says: "Although the authors argue that the difference in findings between the models might be related to different sources of stress and reduced effort in people with severe illness, other important prognostic factors associated with cardiometabolic disease might have biased these findings. The prevalence of poor mental health, such as psychological distress, clinical depression, and anxiety, is higher among patients with cardiometabolic disease than in the general population. Furthermore, compared with people with no stress, those with work stress tend to have a higher prevalence of poor mental health... Nevertheless, their results are provocative and encourage careful attention to work stress reduction among patients with cardiometabolic diseases... Further research into the mechanisms responsible for the these differences in the effects of work stress would not only improve understanding of the prognosis of cardiometabolic disease, but also inform health policy makers and guideline committees about the need for sex-specific workplace interventions for the treatment and management of cardiometabolic disease."
-end-
NOTES TO EDITORS

This study was funded by NordForsk, UK Medical Research Council, and Academy of Finland. It was conducted by researchers from University College London, Helsinki Institute of Life Science, University of Helsinki, University of Turku, University of Bristol, University of Uppsala, Stockholm County Council, Karolinska Institutet, University of Düsseldorf, Jönköping University, Stress Research Institute, Inserm UMS 011, Versailles-Saint Quentin University, Mid Sweden University, Finnish Institute of Occupational Health, SWPS University of Social Sciences and Humanities in Wroclaw, Queen's University Belfast, National Research Centre for the Working Environment, University of Copenhagen, University of Copenhagen, Folkhälsan Research Center, University of Skövde, University of Kent, Turku University Hospital, Uppsala University, Helsinki University Hospital, University of Oulu.

[1] Quote direct from author and cannot be found in the text of the Article.

[2] Based on age-standardised death rates of 150 deaths per 10000 men every year in men with cardiometabolic disease with job strain, versus 98 deaths per 10000 men per year in men with cardiometabolic disease without job strain.

IF YOU WISH TO PROVIDE A LINK FOR YOUR READERS, PLEASE USE THE FOLLOWING, WHICH WILL GO LIVE AT THE TIME THE EMBARGO LIFTS: http://www.thelancet.com/journals/landia/article/PIIS2213-8587(18)30140-2/fulltext.

The Lancet

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.